BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 24535671)

  • 1. NUP98-PHF23 is a chromatin-modifying oncoprotein that causes a wide array of leukemias sensitive to inhibition of PHD histone reader function.
    Gough SM; Lee F; Yang F; Walker RL; Zhu YJ; Pineda M; Onozawa M; Chung YJ; Bilke S; Wagner EK; Denu JM; Ning Y; Xu B; Wang GG; Meltzer PS; Aplan PD
    Cancer Discov; 2014 May; 4(5):564-77. PubMed ID: 24535671
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanistic insights into chromatin targeting by leukemic NUP98-PHF23 fusion.
    Zhang Y; Guo Y; Gough SM; Zhang J; Vann KR; Li K; Cai L; Shi X; Aplan PD; Wang GG; Kutateladze TG
    Nat Commun; 2020 Jul; 11(1):3339. PubMed ID: 32620764
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thymic precursor cells generate acute myeloid leukemia in NUP98-PHF23/NUP98-HOXD13 double transgenic mice.
    Kundu S; Park ES; Chung YJ; Walker RL; Zhu YJ; Negi V; Meltzer PS; Aplan PD
    Sci Rep; 2019 Nov; 9(1):17213. PubMed ID: 31748606
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Haematopoietic malignancies caused by dysregulation of a chromatin-binding PHD finger.
    Wang GG; Song J; Wang Z; Dormann HL; Casadio F; Li H; Luo JL; Patel DJ; Allis CD
    Nature; 2009 Jun; 459(7248):847-51. PubMed ID: 19430464
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation of differentiation by a PHD domain in the NUP98-PHF23 fusion protein.
    Reader JC; Leng Q; Rassool FV; Ning Y
    Leuk Res; 2010 Aug; 34(8):1094-7. PubMed ID: 20219246
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NUP98 Fusion Proteins Interact with the NSL and MLL1 Complexes to Drive Leukemogenesis.
    Xu H; Valerio DG; Eisold ME; Sinha A; Koche RP; Hu W; Chen CW; Chu SH; Brien GL; Park CY; Hsieh JJ; Ernst P; Armstrong SA
    Cancer Cell; 2016 Dec; 30(6):863-878. PubMed ID: 27889185
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The menin-MLL1 interaction is a molecular dependency in NUP98-rearranged AML.
    Heikamp EB; Henrich JA; Perner F; Wong EM; Hatton C; Wen Y; Barwe SP; Gopalakrishnapillai A; Xu H; Uckelmann HJ; Takao S; Kazansky Y; Pikman Y; McGeehan GM; Kolb EA; Kentsis A; Armstrong SA
    Blood; 2022 Feb; 139(6):894-906. PubMed ID: 34582559
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NUP98-PHF23 fusion is recurrent in acute myeloid leukemia and shares gene expression signature of leukemic stem cells.
    Ho H; Skaist AM; Pallavajjala A; Yonescu R; Batista D; Wheelan SJ; Ning Y
    Leuk Res; 2016 Jun; 45():1-7. PubMed ID: 27060678
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A cryptic translocation leading to NUP98-PHF23 fusion in AML.
    Ning Y
    Best Pract Res Clin Haematol; 2016 Dec; 29(4):320-323. PubMed ID: 27890253
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nup98-HoxA9 immortalizes myeloid progenitors, enforces expression of Hoxa9, Hoxa7 and Meis1, and alters cytokine-specific responses in a manner similar to that induced by retroviral co-expression of Hoxa9 and Meis1.
    Calvo KR; Sykes DB; Pasillas MP; Kamps MP
    Oncogene; 2002 Jun; 21(27):4247-56. PubMed ID: 12082612
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NUP98-MLL fusion in human acute myeloblastic leukemia.
    Kaltenbach S; Soler G; Barin C; Gervais C; Bernard OA; Penard-Lacronique V; Romana SP
    Blood; 2010 Sep; 116(13):2332-5. PubMed ID: 20558618
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential and common leukemogenic potentials of multiple NUP98-Hox fusion proteins alone or with Meis1.
    Pineault N; Abramovich C; Ohta H; Humphries RK
    Mol Cell Biol; 2004 Mar; 24(5):1907-17. PubMed ID: 14966272
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MLL is essential for NUP98-HOXA9-induced leukemia.
    Shima Y; Yumoto M; Katsumoto T; Kitabayashi I
    Leukemia; 2017 Oct; 31(10):2200-2210. PubMed ID: 28210005
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NUP98-NSD1 links H3K36 methylation to Hox-A gene activation and leukaemogenesis.
    Wang GG; Cai L; Pasillas MP; Kamps MP
    Nat Cell Biol; 2007 Jul; 9(7):804-12. PubMed ID: 17589499
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The SQSTM1-NUP214 fusion protein interacts with Crm1, activates Hoxa and Meis1 genes, and drives leukemogenesis in mice.
    Lavau CP; Aumann WK; Sze SK; Gupta V; Ripple K; Port SA; Kehlenbach RH; Wechsler DS
    PLoS One; 2020; 15(4):e0232036. PubMed ID: 32343715
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Leukemogenic properties of NUP98-PMX1 are linked to NUP98 and homeodomain sequence functions but not to binding properties of PMX1 to serum response factor.
    Hirose K; Abramovich C; Argiropoulos B; Humphries RK
    Oncogene; 2008 Oct; 27(46):6056-67. PubMed ID: 18604245
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NUP98-HOXA9 bearing therapy-related myeloid neoplasm involves myeloid-committed cell and induces HOXA5, EVI1, FLT3, and MEIS1 expression.
    Burillo-Sanz S; Morales-Camacho RM; Caballero-Velázquez T; Vargas MT; García-Lozano JR; Falantes JF; Prats-Martín C; Bernal R; Pérez-Simón JA
    Int J Lab Hematol; 2016 Feb; 38(1):64-71. PubMed ID: 26418229
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functional analysis of the NUP98-CCDC28A fusion protein.
    Petit A; Ragu C; Soler G; Ottolenghi C; Schluth C; Radford-Weiss I; Schneider-Maunoury S; Callebaut I; Dastugue N; Drabkin HA; Bernard OA; Romana S; Penard-Lacronique V
    Haematologica; 2012 Mar; 97(3):379-87. PubMed ID: 22058212
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induction of acute myeloid leukemia in mice by the human leukemia-specific fusion gene NUP98-HOXD13 in concert with Meis1.
    Pineault N; Buske C; Feuring-Buske M; Abramovich C; Rosten P; Hogge DE; Aplan PD; Humphries RK
    Blood; 2003 Jun; 101(11):4529-38. PubMed ID: 12543865
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NUP98-HOXA9-transgenic zebrafish develop a myeloproliferative neoplasm and provide new insight into mechanisms of myeloid leukaemogenesis.
    Forrester AM; Grabher C; McBride ER; Boyd ER; Vigerstad MH; Edgar A; Kai FB; Da'as SI; Payne E; Look AT; Berman JN
    Br J Haematol; 2011 Oct; 155(2):167-81. PubMed ID: 21810091
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.